The best treatment of juxtarenal aortic occlusion is and will be open surgery

M. M. Marrocco-Trischitta, L. Bertoglio, Y. Tshomba, A. Kahlberg, E. M. Marone, R. Chiesa

Research output: Contribution to journalArticle

Abstract

Occlusion of the infrarenal aorta (IAO) represents from 3% to 8.5% of aortoiliac occlusive diseases, and is a variant of TransAtlantic Inter-Society Consensus (TASC) Type D lesions. Two different patterns of IAO can be identified: Distal and proximal, or iuxtarenal. The former typically spares the origin of the inferior mesenteric artery, and is associated with the classic Leriche clinical triad. The latter extends cephalad approaching the level of the renal arteries, and may also cause acute renal failure, intestinal infarction, and even paraplegia due to the proximal propagation of aortic thrombosis. Endovascular treatment for TASC Type C and D lesions as a whole provides impressive results in terms of periprocedural morbidity, secondary patency rates, and of course less invasivity in comparison to open surgery. However, when complete aortic occlusions, and particularly juxtarenal occlusion, are specifically addressed, the reported results are in fact sobering, both in terms of technical success rates, and perioperative complications. Surgery repair of juxtarenal aortic occlusion, namely aortic endarterectomy and bypass grafting, is a challenging procedure that requires almost invariably aortic cross-clamping above the level of the renal arteries, and may be associated with significant morbidity and mortality. Nevertheless, it currently provides unmatched perioperative and long-term results, and should be regarded as the treatment of choice.

Original languageEnglish
Pages (from-to)307-312
Number of pages6
JournalJournal of Cardiovascular Surgery
Volume53
Issue number3
Publication statusPublished - Jun 2012

Fingerprint

Renal Artery
Aorta
Inferior Mesenteric Artery
Morbidity
Endarterectomy
Paraplegia
Acute Kidney Injury
Constriction
Infarction
Thrombosis
Mortality

Keywords

  • Aorta
  • Arterial occlusive diseases
  • Leriche syndrome

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

The best treatment of juxtarenal aortic occlusion is and will be open surgery. / Marrocco-Trischitta, M. M.; Bertoglio, L.; Tshomba, Y.; Kahlberg, A.; Marone, E. M.; Chiesa, R.

In: Journal of Cardiovascular Surgery, Vol. 53, No. 3, 06.2012, p. 307-312.

Research output: Contribution to journalArticle

Marrocco-Trischitta, M. M. ; Bertoglio, L. ; Tshomba, Y. ; Kahlberg, A. ; Marone, E. M. ; Chiesa, R. / The best treatment of juxtarenal aortic occlusion is and will be open surgery. In: Journal of Cardiovascular Surgery. 2012 ; Vol. 53, No. 3. pp. 307-312.
@article{30d91e48811946a1b390cd254cdac60f,
title = "The best treatment of juxtarenal aortic occlusion is and will be open surgery",
abstract = "Occlusion of the infrarenal aorta (IAO) represents from 3{\%} to 8.5{\%} of aortoiliac occlusive diseases, and is a variant of TransAtlantic Inter-Society Consensus (TASC) Type D lesions. Two different patterns of IAO can be identified: Distal and proximal, or iuxtarenal. The former typically spares the origin of the inferior mesenteric artery, and is associated with the classic Leriche clinical triad. The latter extends cephalad approaching the level of the renal arteries, and may also cause acute renal failure, intestinal infarction, and even paraplegia due to the proximal propagation of aortic thrombosis. Endovascular treatment for TASC Type C and D lesions as a whole provides impressive results in terms of periprocedural morbidity, secondary patency rates, and of course less invasivity in comparison to open surgery. However, when complete aortic occlusions, and particularly juxtarenal occlusion, are specifically addressed, the reported results are in fact sobering, both in terms of technical success rates, and perioperative complications. Surgery repair of juxtarenal aortic occlusion, namely aortic endarterectomy and bypass grafting, is a challenging procedure that requires almost invariably aortic cross-clamping above the level of the renal arteries, and may be associated with significant morbidity and mortality. Nevertheless, it currently provides unmatched perioperative and long-term results, and should be regarded as the treatment of choice.",
keywords = "Aorta, Arterial occlusive diseases, Leriche syndrome",
author = "Marrocco-Trischitta, {M. M.} and L. Bertoglio and Y. Tshomba and A. Kahlberg and Marone, {E. M.} and R. Chiesa",
year = "2012",
month = "6",
language = "English",
volume = "53",
pages = "307--312",
journal = "Journal of Cardiovascular Surgery",
issn = "0021-9509",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "3",

}

TY - JOUR

T1 - The best treatment of juxtarenal aortic occlusion is and will be open surgery

AU - Marrocco-Trischitta, M. M.

AU - Bertoglio, L.

AU - Tshomba, Y.

AU - Kahlberg, A.

AU - Marone, E. M.

AU - Chiesa, R.

PY - 2012/6

Y1 - 2012/6

N2 - Occlusion of the infrarenal aorta (IAO) represents from 3% to 8.5% of aortoiliac occlusive diseases, and is a variant of TransAtlantic Inter-Society Consensus (TASC) Type D lesions. Two different patterns of IAO can be identified: Distal and proximal, or iuxtarenal. The former typically spares the origin of the inferior mesenteric artery, and is associated with the classic Leriche clinical triad. The latter extends cephalad approaching the level of the renal arteries, and may also cause acute renal failure, intestinal infarction, and even paraplegia due to the proximal propagation of aortic thrombosis. Endovascular treatment for TASC Type C and D lesions as a whole provides impressive results in terms of periprocedural morbidity, secondary patency rates, and of course less invasivity in comparison to open surgery. However, when complete aortic occlusions, and particularly juxtarenal occlusion, are specifically addressed, the reported results are in fact sobering, both in terms of technical success rates, and perioperative complications. Surgery repair of juxtarenal aortic occlusion, namely aortic endarterectomy and bypass grafting, is a challenging procedure that requires almost invariably aortic cross-clamping above the level of the renal arteries, and may be associated with significant morbidity and mortality. Nevertheless, it currently provides unmatched perioperative and long-term results, and should be regarded as the treatment of choice.

AB - Occlusion of the infrarenal aorta (IAO) represents from 3% to 8.5% of aortoiliac occlusive diseases, and is a variant of TransAtlantic Inter-Society Consensus (TASC) Type D lesions. Two different patterns of IAO can be identified: Distal and proximal, or iuxtarenal. The former typically spares the origin of the inferior mesenteric artery, and is associated with the classic Leriche clinical triad. The latter extends cephalad approaching the level of the renal arteries, and may also cause acute renal failure, intestinal infarction, and even paraplegia due to the proximal propagation of aortic thrombosis. Endovascular treatment for TASC Type C and D lesions as a whole provides impressive results in terms of periprocedural morbidity, secondary patency rates, and of course less invasivity in comparison to open surgery. However, when complete aortic occlusions, and particularly juxtarenal occlusion, are specifically addressed, the reported results are in fact sobering, both in terms of technical success rates, and perioperative complications. Surgery repair of juxtarenal aortic occlusion, namely aortic endarterectomy and bypass grafting, is a challenging procedure that requires almost invariably aortic cross-clamping above the level of the renal arteries, and may be associated with significant morbidity and mortality. Nevertheless, it currently provides unmatched perioperative and long-term results, and should be regarded as the treatment of choice.

KW - Aorta

KW - Arterial occlusive diseases

KW - Leriche syndrome

UR - http://www.scopus.com/inward/record.url?scp=84864743606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864743606&partnerID=8YFLogxK

M3 - Article

C2 - 22695263

AN - SCOPUS:84864743606

VL - 53

SP - 307

EP - 312

JO - Journal of Cardiovascular Surgery

JF - Journal of Cardiovascular Surgery

SN - 0021-9509

IS - 3

ER -